Tripletail Wealth Management »

Silverback Therapeutics shares owned by Tripletail Wealth Management

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Tripletail Wealth Management from 13F filings

Historical chart of Tripletail Wealth Management investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Tripletail Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Tripletail Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.7k 450 10.36

More positions owned by Tripletail Wealth Management

John Bean Technologies Corporation (JBTM)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Pgim Etf Tr Pgim Ultra Sh Bd (PULS)
Pacer Fds Tr Metaurus Cap 400 (QDPL)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Arista Networks Com Shs (ANET)
Pacer Fds Tr Us Lrg Cp Cash (COWG)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Northern Lts Fd Tr Iv Main Sectr Rotn (SECT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Tripletail Wealth Management

Top funds holding Silverback Therapeutics

RA Capital Management
OrbiMed Advisors
Deerfield Management Company
BlackRock
Rubric Capital Management
Sr One Capital Management
Vanguard Group
Standard Life Aberdeen
State Street Corporation
Alliancebernstein
Franklin Resources
Citadel Advisors
Casdin Capital
Geode Capital Management
Southpoint Capital Advisors

View all funds holding Silverback Therapeutics